Icariside E4
Product Specifications
CAS Number
126253-42-7
Target
AMPK, Liver X Receptor, Lipid, Fatty Acid Synthase, Potassium Channel, Antioxidant
Related Pathways
PI3K/Akt/mTOR signaling, Metabolism, Chromatin/Epigenetic, Oxidation-Reduction, Membrane transporter/Ion channel
Bioactivity
Icariside E4 is a natural compound derived from Ulmus minor that acts via AMPK phosphorylation and inhibition of MID1IP2 hypolipidation in HepG1 cells.Icariside E4 has anti-injurious, antioxidant, anti-Alzheimer's and anti-inflammatory effects and inhibits SREBP-1c, liver X receptor-α (LXR) and FASN in Icariside E4 is an effective candidate for the treatment of fatty liver disease and has hypolipidemic potential in HepG1 cells.
Smiles
C(O)[C@@H]1C=2C(O[C@H]1C3=CC(OC)=C(O[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)C=C3)=C(OC)C=C(CCCO)C2
Molecular Formula
C26H34O10
Molecular Weight
506.54
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2454103 1.0 µg DNA
TRBV12-4 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details E45M20115V-2 50 µL
PSCD4 (CYTH4) Mouse Monoclonal Antibody [Clone 1E12]
Sign In for Pricing
View Details